HOME | SCIENTIFIC SESSIONS AND PRESENTATIONS
CONFERENCE SUPPORTERS | ABSTRACTS | TRADESHOW | PHOTO GALLERY

SCIENTIFIC SESSIONS AND PRESENTATIONS

Disclaimer: This information has been provided for viewing purposes only.
You MUST contact the appropriate faculty member before using any material, statistics, quotes, tables, or graphs for your own use.

CLICK ON SESSION TITLE TO VIEW SLIDE PRESENTATION

Jump to: Friday, 7/10/2009 | Saturday, 7/11/2009 | Sunday, 7/12/2009

Friday, 7/10/2009

07:30 AM to 11:30 AM	Hypertension Academy
	Overview	Chair	John M. Flack, MD, MPH
	Basic Principles of Effective Hypertension Therapeutics	Speaker	John M. Flack, MD, MPH
	Hypertension Case Management	Speaker	Angela L. Brown, MD
	Hypertension Case Management	Speaker	Jackson T. Wright, Jr., MD
	Effective BP Lowering and Target Organ Protection in Patients with Compromised Kidney Function	Speaker	Errol D. Crook, MD
	New Antihypertensive Agents	Speaker	George L. Bakris, MD
	Optimal Utilization Diuretics in Antihypertensive Regimens	Speaker	Domenic A. Sica, MD

11:45 AM to 1:00 PM	Opening Ceremony/Neil Shulman Lecture:
	Welcome	Conference Co-Chair	Keith C. Norris, MD
	Conference Overview and Objectives	Conference Co-Chair	Keith C. Ferdinand, MD
	Introduction and Acknowledgement of ISHIB Founders	Chair	Kenneth A. Jamerson, MD
	Welcome from the City of Chicago		Terry Mason, MD
	Public Health Policy: The Impact of City Health Departments in Shaping Policy		Terry Mason, MD

2:30 PM to 4:00 PM	Plenary Session I	Healthy People 2010 Are We There Yet
	Introduction		Chair	Elijah Saunders, MD
2:35 PM to 2:45 PM	Nebivolol in High-risk, Obese African Americans With Stage 1 hypertension: Effects on Blood Pressure, Nitric Oxide Bioavailability, and Vascular Function		Blue Ribbon Presenter	Nadya Merchant
	Healthy People 2010: The Update		Speaker	Rear Admiral Penelope Slade-Sawyer
	Changing the Cardiovascular profile for African American patients and other high risk minorities		Speaker	Elijah Saunders, MD

4:30 PM to 5:30 PM	Workshop A	Target Organ Damage and the importance of Staging: Cardiovascular Disease
	Introduction		Chair	Otelio S. Randall, MD
	An Overview of Left Ventricular Hypertrophy		Speaker	Carlos Jose Rodriguez, MD, MPH
	High Risk Patients: Kidney Disease, Dialysis and Hypertension		Speaker	Myra A. Kleinpeter, MD

4:30 PM to 5:30 PM	Workshop B	Can We Afford to Insure Everyone
$\\Fileserver.htn.musc.edu\public\eganbm\pictures\Egan 2007.jpg$	Introduction		Chair	Brent M. Egan, MD
	Health and Economic Toll of Uunder- and Uninsured Groups in South Carolina and Beyond: Can We Afford Not to Insure Everyone?”		Speaker	Daniel Lackland, DrPH

6:30 PM to 8:30 PM	Dinner Symposium	Blood Pressure Management and Risk Reduction in African American Patients with Metabolic Syndrome: What are the Best Approaches?
	Welcome/Overview		Chair	Keith C Ferdinand., MD
	Components of the Metabolic Syndrome In African American Patients		Speaker	James R. Sowers, MD
	Inflammatory Markers In Cardiovascular Disease		Speaker	Shawna D. Nesbitt, MD, MS
	Combination Therapy in African Americans With Hypertension And Metabolic Syndrome: What Are The Best Choices?		Speaker	Keith Ferdinand, MD
	Panel Discussion With Audience Response: Cases in Point: Addressing The Challenges in African American Patients With Hypertension And Metabolic Syndrome
SUPPORTED BY:	Daiichi Sankyo

Saturday, 7/11/2009

7:30 AM to 8:30 AM

How to Become More Involved in ISHIB

“Where we are”

Elijah Saunders

“Get more involved”

Shawna Nesbitt

8:30 AM to 10:00 AM	Plenary Session II	Diabetes: New Age is it Beneficial or Harmful
	Introduction		Chair	Kwame Osei, MD
	Introduction		Co-Chairs	Trudy Gaillard, Ph.D., M.S., R.N., C.D.E.
	EFFICACY OF AN AMLODIPINE/OLMESARTAN MEDOXOMIL (AML/OM)-BASED TITRATION REGIMEN IN BLACK OR NON-BLACK PATIENTS WITH HYPERTENSION		Blue Ribbon Presenter	Dean Kereiakas
	Glycemic Targets and Cardiovascular Outcomes: From UKPS, VADT, ADVANCE TO ACCORD		Speaker	David M. Kendall, MD
	Management of Hypertension in African Americans With Diabetes		Speaker	James W. Reed MD
	Management of Lipids in African Americans		Speaker	Anne E. Sumner, MD

11:30 PM to 1:30 PM	Lunch Symposium	"Glycemic Targets in Patients with Type 2 Diabetes: A New Era?"
	Welcome/Overview		Chair	Kwame Osei, MD
	Hypoglycemic Targets: Interpreting Latest Trial Evidence		Speaker	David M. Kendall, MD
	Managing CV Risk in African Americans With Type 2 Diabetes and Hypertension		Speaker	Keith Ferdinand, MD
	Panel Discussion: Managing Risk in an African American Patient With Hypertension and Diabetes		Speaker	Kwame Osei, MD
SUPPORTED BY:	Takeda Pharmaceuticals North America, Inc.

3:30 PM to 4:30 PM	Workshop C	Understanding Genomics: Basics and Beyond
	Introduction		Chair	Rick A. Kittles, PhD
	An Update on Genomic Profiling: New Technologies and Methodologies		Speaker	John David Carpten, PhD
	Ancestry, Genetic Association, and Hypertension		Speaker	James Wilson, MD

3:30 PM to 4:30 PM	Workshop D	*Heart Failure*
	Introduction		Chair	Anekwe Onwuanyi, MD
	Comparison of Heart Failure in the Minority Populations		Speaker	Ilena Pina, MD
	Systolic and Diastolic Heart Failure		Speaker	Anekwe Onwuanyi, MD

6:30 PM to 8:30 PM	Dinner Symposium	Oxidative Stress, Endothelial Function and Beta Blockade in Hypertensive Disease: A Fresh Look at African American Patients
	Welcome/Overview		Chair	Kenneth A. Jamerson, MD
	Oxidative Stress, Endothelial Function, and Beta Blockade: Newest Findings		Speaker	Gary H. Gibbons, MD
	Hypertensive Disease Management in African Americans: Interpreting The Role of Beta Blockade		Speaker	Elizabeth Ofili, MD
	Faculty Case Discussion With Audience Response: An Elderly African American Patient With Hypertension and Angina		Speaker	Kenneth A. Jamerson, MD
SUPPORTED BY:	Forest Laboratories

Sunday, 7/12/2009

7:30 AM to 8:30 AM	Ask the Experts, A Discussion of Practical Case Studies

Keith Ferdinand	David Kountz	Keith Norris

8:30 AM to 10:00 AM	Plenary Session III
	Introduction	Chair	Janice P. Lea, MD
	RELATIONSHIP BETWEEN INFLAMMATION AND HYPERTENSION IN BLACKS	Blue Ribbon Presenter	Ralph Watson
	Chronic Kidney Disease Staging: The Pros and Cons	Speaker	Susanne B. Nicholas , MD, PhD, MPH, FASN
	Management of Hypertension in the CKD Patient	Speaker	Janice P. Lea, MD

11:00 AM to 12:00 PM	Workshop E	Treatment of Anemia and Metabolic Derrangements and Chronic Kidney Disease What is Appropriate and What is Not
	Introduction		Co-Chairs	Errol D. Crook, MD Eddie L. Greene, MD
	Treatment of Anemia in CKD: Impact on CVD		Speaker	R. Michael Culpepper, MD
	Impact of Treating Elevated Lipids, Glucose, and Inflammatory Markers on CKD		Speaker	J. Kevin Tucker, MD

11:00 AM to 12:00 PM	Workshop F	Imaging Subclinical and Identifying Patients at High Risk for Cardiovascular Disease
	Introduction		Chair	Keith C. Norris, MD
	Vitamin D Overview – What Clinicians Need to Know		Speaker	Diane E. Wallis, MD
	Vitamin D and Chronic Kidney Disease		Speaker	Keith C. Norris, MD

1:30 PM to 3:00 PM	Lifestyle Modification Workshop
	Introduction: Improving Adhereance and Self-Management Within The Chronic Care Model	Chair	Rosalind M. Peters, PhD, RN
	Office System Factors Affecting Adherence: Decision-Support Mechanisms	Speaker	Timothy J. Long, MD
	Provider Factors Affecting Adherence: Cultural Competency and Sensitivity	Speaker	Debra J. Barksdale, PhD, RN, FNP-BC, ANB-BC, CNE
	Patient Factors Affecting Adherence: Empowering Patients for Self-Management	Speaker	Ramona Benkert, PhD, RN